Regeneron Pharmaceuticals (NASDAQ:REGN): Q1 Non-GAAP EPS of $6.60 beats by $0.51; GAAP EPS of $5.43 misses by $0.07.
Revenue of $1.83B (+33.6% Y/Y) beats by $20M.
https://seekingalpha.com/news/3568910-regeneron-pharmaceuticals-eps-beats-0_51-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.